Sounds creepy. Wish they would say more about the New Zealand trials and why/what they plan to do because of it. OTC supplement? Also anxious to hear any update on their European trials. I wonder if the 'creep' you see is real maybe because of their inside knowledge of the data they have from these two trials so far? I can't believe they just blindly test anatabine on 'healthy' individuals without regard to issues they may have that could be affected by these dosages. Well, more to come---in slow motion. Worried also about their last private offering that seems to hit a wall. How does this impact their future plans? Based on what I've seen so far re licensing, joint-ventures, and buy-outs, the big pharmas seem to wait until they get some positive data from the clinical trials, ie phase 2 or phase 3 before making offers. Can they make it? Also wondering what data they got when they were doing the Anatabloc trials on Alzheimers? Good, bad, or nada???
Keep watching. Though the stock is creeping down, there is someone who seems to buy thousand share blocks of stock while shorts or others sell in 100 share blocks? Hey Johnny what'cha doing?
